跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-LEFLUNOMIDE leflunomide 20mg tablet bottle - TGA Drug Approval Details
Approvals
/
TGA
/
APO-LEFLUNOMIDE leflunomide 20mg tablet bottle
Approved
STANDARD
APO-LEFLUNOMIDE leflunomide 20mg tablet bottle
Arrotex Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
b2dbcdba9ab76321
Company
Arrotex Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
b2dbcdba9ab76321
Product Name
APO-LEFLUNOMIDE leflunomide 20mg tablet bottle
Artg Id
251993
Artg Name
APO-LEFLUNOMIDE leflunomide 20mg tablet bottle
Sponsor
Arrotex Pharmaceuticals Pty Ltd
Company Detail Path
/organization/arrotex-pharmaceuticals-pty-ltd
Artg Date
2015-12-22
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/ef337a95e51d9812d0e272ac6793291d.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/0a45655171d954a7ec874400e3a86db6.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
b2dbcdba9ab76321
Type
Standard
Back to TGA Approvals